Package 68788-7819-6

{"route": ["ORAL"], "spl_id": "be601110-37b2-4607-8b15-88bbce434fbe", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993503"], "spl_set_id": ["d1d1ed19-e111-4652-a0d4-9406e6f73e9f"], "manufacturer_name": ["Preferred Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-7819-3)", "package_ndc": "68788-7819-3", "marketing_start_date": "20201113"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-7819-6)", "package_ndc": "68788-7819-6", "marketing_start_date": "20201113"}, {"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-7819-9)", "package_ndc": "68788-7819-9", "marketing_start_date": "20201113"}], "brand_name": "Bupropion Hydrochloride SR", "product_id": "68788-7819_be601110-37b2-4607-8b15-88bbce434fbe", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "68788-7819", "generic_name": "bupropion hydrochloride", "labeler_name": "Preferred Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA205794", "marketing_category": "ANDA", "marketing_start_date": "20201113", "listing_expiration_date": "20261231"}